SOUTH SAN FRANCISCO, Calif., Nov. 21, 2013 (GLOBE NEWSWIRE) -- Full Spectrum Genetics, Inc., a privately-held protein engineering platform and product company, today announced the extension of their first project with a leading global pharmaceutical company for the purpose of generating multiple novel therapeutic protein product candidates. The extended project will utilize FSG's new competitive MapEng™ system to provide information on the specificity of the therapeutic protein variants discovered during the initial phase of the project.
Help employers find you! Check out all the jobs and post your resume.
